Skip to main content
. 2021 Sep 1;34(5):1659–1668. doi: 10.1007/s40620-021-01130-x

Table 2.

Risk factors according to AKI (n=2025)

Factor AKI N (%) (n=396) No AKI N (%) (n=1629) P value§
Gender
 Male 234 (59.1) 882 (54.1) 0.076
 Female 162 (40.9) 747 (45.9)
Birth weight
  ≤ 2.5 kg 268 (67.7) 1245 (76.4)  < 0.001**
  > 2.5 kg 128 (32.3) 384 (23.6)
Gestational age
 Term 124 (31.3) 448 (27.5)  < 0.001**
 29–37 weeks 137 (34.6) 957 (58.7)
  < 29 weeks 135 (34.1) 224 (13.8)
Apgar score at 5 min
  < 5 13 (03.3) 33 (02.0) 0.132
  ≥ 5 383 (96.7) 1596 (98.0)
Nephrotoxic medications
 Aminoglycoside 316 (79.8) 1349 (82.8) 0.159
 Vancomycin 242 (61.1) 455 (27.9)  < 0.001**
 Ceftazidime 54 (13.6) 83 (05.1)  < 0.001**
 Amphotericin B 39 (09.8) 33 (02.0)  < 0.001**
 Loop diuretics 124 (31.3) 145 (08.9)  < 0.001**
 NSAIDs 82 (20.7) 108 (06.6)  < 0.001**
Central line 215 (54.3) 450 (27.6)  < 0.001**
Umbilical atrial catheter 118 (29.8) 176 (10.8)  < 0.001**
Admission temperature < 36 192 (48.5) 841 (51.6) 0.262
Hypoxic ischemic encephalopathy 05 (01.3) 19 (01.2) 0.874
Necrotizing enterocolitis 51 (12.9) 85 (05.2)  < 0.001**
Patent Ductus Arteriosus 88 (22.2) 203 (12.5)  < 0.001**
Respiratory distress syndrome 201 (54.3) 687 (47.6) 0.021**
Premature Rupture of Membrane > 18 h 42 (10.6) 154 (09.5) 0.487
Intraventricular hemorrhage 47 (11.9) 37 (02.3)  < 0.001**
Surgical intervention 149 (37.6) 234 (14.4)  < 0.001**
Mechanical ventilation 252 (63.6) 523 (32.1)  < 0.001**
Positive sepsis 113 (28.5) 212 (13.0)  < 0.001**
Epinephrine infusion 85 (21.5) 60 (03.7)  < 0.001**

AKI Acute Kidney Injury; NSAIDs Non-steroidal anti-inflammatory drugs; GA Gestational age

§P value has been calculated using the Chi square test

**Significant at P < 0.05 level